We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 26

EU adopts joint procurement agreement for pandemic vaccines

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • April 17 2014

The European Commission has approved a joint procurement agreement under which all European Union (EU) member states will be able to "procure

April vote scheduled before EU Parliament on clinical trial data accessibility

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • March 20 2014

The European Parliament has postponed until April 2, 2014, debate on amended draft legislation (20120192 (COD)) that would require phar- maceutical

Public-private EU partnership to fund stem cell banking and distribution

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • February 13 2014

A consortium of public and private partners has reportedly formed to establish a European induced pluripotent stem (iPS) cell bank with the goal of

European markets less than enthusiastic over biosimilars

  • Shook Hardy & Bacon LLP
  • -
  • European Union, USA
  • -
  • December 12 2013

While Europe has had a regulatory approval pathway for biosimilar drug products for some years, their use reportedly remains anemic. Physicians are

R&D for new drugs to treat “neglected diseases” continues to lag

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • October 31 2013

European researchers writing in a medical journal have found that just 4 percent of new therapeutic products registered with drug regulatory

EU trade group issues voluntary code for disclosures by pharma companies

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • July 11 2013

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued a "Code on Disclosure of Transfers of Value from

EU adds pharmaceuticals to water pollution watch list

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • July 11 2013

The European Commission (EC) has added 12 new substances to the European Union's (EU's) priority list of chemicals known to pose a risk to the safety

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • May 16 2013

According to a news source, European Medicines Agency (EMA) Director Guido Rasi intends to appeal interim rulings recently issued by the European

EU medical device manufacturers address plan to change regulatory directives

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • February 8 2013

Eucomed, an organization that represents the interests of the European medical device industry, has issued a position paper that assesses a number of